The Centre for Systems Medicine is delighted to announce another speaker to its 2015 seminar series: Prof. Graeme Bell University of Chicago Venue: Houston Lecture Theatre, RCSI, 4.30pm Thursday 22nd …
The Centre for Systems Medicine is pleased to announce another speaker to our seminar series. Dr. Maciej Dobrzynski Systems Biology Ireland, University College Dublin, Belfield, Dublin 4 http://www.ucd.ie/research/people/systemsbiologyireland/drmaciejdobrzynski/ Title: Single-cell …
The CASyM roadmap is published After a two year cross-disciplinary consultation process, the Coordinating Action Systems Medicine (CASyM) has published its European implementation strategy (roadmap) for Systems Medicine. The vision …
Friday 5th December 2014, at 2.00 pm Decisions, decisions: Regulation of apoptotic and necroptotic cell death in skin cancer Dr Martin Leverkus Section for Molecular Dermatology, Department of Dermatology and …
Albert Lecture Theatre, 4pm, Tuesday 28th of October 2014. James D. Johnson, Ph.D. Oxford University Visiting Professor of Integrated Physiology, OCDEM/WTCHG,Visiting Fellow of Harris-Manchester College Associate Professor | Medicine | Cellular …
Exploiting addiction to apoptosis inhibitors in cancer Speaker: Dr Daniel Longley, Centre for Cancer Research and Cell Biology, Queen’s University Belfast Monday 6th October 2014, at 4.00 pm Dear Colleagues, …
The RCSI Centre for Systems Medicine will host a seminar by Dr Pavel Souček (NIPH, Prague) on the molecular mechanisms of responses to major anticancer drugs by Dr Pavel Souček …
Low selenium levels are associated with colorectal cancer development New evidence that the micronutrient selenium is involved in colorectal cancer (bowel cancer) has been discovered by Dr David Hughes from …
At the threshold of personalised cancer treatment Published by newsroom editor on Friday, 16/05/2014 New tumour profiling methods developed by EU-funded researchers aim to help doctors adjust treatments for colorectal …
HRB-funded research in the Centre for Systems Medicine could lead to a new biomarker for colorectal cancer. New evidence that a common gut bacterium is involved in colorectal cancer has …